Literature DB >> 10742343

Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn. Committee on Drugs. American Academy of Pediatrics.

.   

Abstract

Psychoactive drugs are those psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. This statement will limit its scope to drug selection guidelines for those psychoactive agents used during pregnancy for prevention or treatment of the following common psychiatric disorders: schizophrenia, major depression, bipolar disorder, panic disorder, and obsessive-compulsive disorder. The statement assumes that pharmacologic therapy is needed to manage the psychiatric disorder. This decision requires thoughtful psychiatric and obstetric advice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10742343     DOI: 10.1542/peds.105.4.880

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

Review 1.  Benefits and risks to mother and infant of drug treatment for postnatal depression.

Authors:  Shaila Misri; Xanthoula Kostaras
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

2.  Antipsychotic drugs disrupt normal development in Caenorhabditis elegans via additional mechanisms besides dopamine and serotonin receptors.

Authors:  Dallas R Donohoe; Eric J Aamodt; Elizabeth Osborn; Donard S Dwyer
Journal:  Pharmacol Res       Date:  2006-08-07       Impact factor: 7.658

Review 3.  Serotonin reuptake inhibitor-induced perinatal complications.

Authors:  Salvatore Gentile
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

4.  Neonatal exposure to citalopram selectively alters the expression of the serotonin transporter in the hippocampus: dose-dependent effects.

Authors:  Kristin J Weaver; Ian A Paul; Rick C S Lin; Kimberly L Simpson
Journal:  Anat Rec (Hoboken)       Date:  2010-11       Impact factor: 2.064

5.  Perinatal Generalized Anxiety Disorder: Assessment and Treatment.

Authors:  Shaila Misri; Jasmin Abizadeh; Shawn Sanders; Elena Swift
Journal:  J Womens Health (Larchmt)       Date:  2015-06-30       Impact factor: 2.681

6.  Should pregnant women with substance use disorders be managed differently?

Authors:  Verena Metz; Birgit Köchl; Gabriele Fischer
Journal:  Neuropsychiatry (London)       Date:  2012-01-25

7.  Psychopharmacologic management of opioid-dependent women during pregnancy.

Authors:  Peter R Martin; Amelia M Arria; Gabriele Fischer; Karol Kaltenbach; Sarah H Heil; Susan M Stine; Mara G Coyle; Peter Selby; Hendrée E Jones
Journal:  Am J Addict       Date:  2009 Mar-Apr

8.  Use of escitalopram during pregnancy: navigating towards international guidelines and the real world.

Authors:  Salvatore Gentile
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

9.  An Update on Mood and Anxiety Disorders During Pregnancy and the Postpartum Period.

Authors:  Lori L. Altshuler; Victoria Hendrick; Lee S. Cohen
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2000-12

Review 10.  Developmental effects of SSRIs: lessons learned from animal studies.

Authors:  Xenia Borue; John Chen; Barry G Condron
Journal:  Int J Dev Neurosci       Date:  2007-07-07       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.